trending Market Intelligence /marketintelligence/en/news-insights/trending/1AVBR4f5RsFiOF0wr6N-Ug2 content esgSubNav
In This List

Arix Bioscience leads $30M financing for Atox Bio

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Arix Bioscience leads $30M financing for Atox Bio

Arix Bioscience plc led an oversubscribed $30 million series F financing round for Atox Bio.

Participants included new investors Adams Street Partners, Asahi Kasei Corp. and additional undisclosed investors, plus existing investors SR One, OrbiMed, Lundbeckfonden Ventures, Becker and Integra Holdings.

Arix Bioscience is investing $8 million for an equity stake in Atox Bio.

As part of the financing, Arix Bioscience's Jonathan Tobin will be appointed a director of Atox Bio.